Genetic factors in drug therapy.
D000293:Adolescent; D000368:Aged; D000429:Alcohol Oxidoreductases / Q000378:metabolism; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D002648:Child; D005260:Female; D005901:Glaucoma / Q000235:genetics; D006801:Humans; D006830:Hydralazine / Q000378:metabolism; D007538:Isoniazid / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D008099:Liver / Q000201:enzymology / Q000378:metabolism; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010597:Pharmacogenetics; D010615:Phenacetin / Q000378:metabolism; D010624:Phenelzine / Q000378:metabolism; D010641:Phenotype; D010672:Phenytoin / Q000009:adverse effects / Q000378:metabolism; D011110:Polymorphism, Genetic; D011115:Polyneuropathies / Q000139:chemically induced; D013307:Streptomycin / Q000627:therapeutic use; D013418:Sulfamethazine / Q000378:metabolism; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000925:Anticoagulants; D004364:Pharmaceutical Preparations; D006830:Hydralazine; D013418:Sulfamethazine; D010672:Phenytoin; D000429:Alcohol Oxidoreductases; D010615:Phenacetin; D010624:Phenelzine; D007538:Isoniazid; D013307:Streptomycin